Following Its 52-Week Low, Esperion Therapeutics Inc (NASDAQ: ESPR)’S Share Price Rose 6.37% And Its YTD Numbers Fell -28.86%
During the recent session, Esperion Therapeutics Inc (NASDAQ:ESPR)’s traded shares were 0.57 million, with the beta value of the company hitting 0.82. At the last